DV
Dividend Vision

RVMD — Revolution Medicines Inc.

Revolution Medicines Inc. (RVMD)

Total return is 604.9% over the past 6.5 years, 452.2 points ahead of SPY at 152.7%. Its deepest 1-year drawdown was 25.0%.

This is a single-stock holding in Revolution Medicines Inc., a biotech company focused on developing targeted therapies. The fund does not currently pay distributions and carries no listed expense ratio or asset information, making it unsuitable for income-focused investors seeking regular dividend payments. This equity holding appeals primarily to growth-oriented investors interested in exposure to the pharmaceutical development sector.

RVMD key facts

Asset type
Stock
Asset class
Equity
Inception date
02/13/2020
Distribution frequency
None
Last close
$203.71
Market cap
$43,662,471,168
Average volume
784252.0
Beta
1.403
Payout ratio
0.0
Forward P/E
0.0
EPS
$-8.86